Rosenstock, J., Aggarwal, N., Polidori, D., et al. (2012) Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes. Diabetes Care, 35, 1232-1238. http://dx.doi.org/10.2337/dc11-1926
 Stenl?f, K., Cefalu, W., Kim, K., et al. (2013) Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise. Diabetes, Obesity and Metabolism, 4, 372-382.